SCHEMBL15569142

SCHEMBL15569142

O=c1oc(-c2ccc(Br)cc2)cc2ccncc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 1/20 0.46
MITF O75030 1/20 0.46
MAOB P27338 3/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
POLB P06746 1/20 0.43
MAPK1 P28482 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TNKS O95271 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
ALOX5 P09917 1/20 0.40
MAOA P21397 1/20 0.39
GAA P10253 1/20 0.39
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15567364 0.88 PTGES (0.46) PTGESMITFMAOBKDM4EALDH1A1
SCHEMBL15568125 0.78 PTGES (0.75) PTGESMITFMAOBKDM4EALDH1A1
SCHEMBL3326788 0.75 PTGES (0.51) PTGESMITFKDM4EALDH1A1POLB
SCHEMBL5309603 0.75 MAOB (0.60) MAOBTNKSNPC1RAB9AMAOA
SCHEMBL2370723 0.71 MAPT (0.40) MAOBKDM4EPOLBMAPTTDP1
SCHEMBL15775877 0.71 RAB9A (0.51) PTGESMITFMAOBKDM4EALDH1A1
SCHEMBL15568360 0.71 CCNB2 (0.44) KDM4EALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL15567401 0.70 PTGES (0.43) PTGESMITFKDM4EALDH1A1MAPT
SCHEMBL7264074 0.68 F7 (0.40) KDM4EALDH1A1POLBMAPTHPGD
SCHEMBL1424093 0.65 PRKCA (0.45) PTGESMITFKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2882714-B1 (AZA-)ISOQUINOLINONE DERIVATIVES MERCK PATENT GMBH (DE) 2019-11-13 EP disclosed
EP-2882714-B1 (AZA-)ISOQUINOLINONE DERIVATIVES MERCK PATENT GMBH (DE) 2019-11-13 EP disclosed
US-9376433-B2 (AZA-)isoquinolinone derivatives MERCK PATENT GMBH (DE) 2016-06-28 US disclosed
US-9376433-B2 (AZA-)isoquinolinone derivatives MERCK PATENT GMBH (DE) 2016-06-28 US disclosed
US-9376433-B2 (AZA-)isoquinolinone derivatives MERCK PATENT GMBH (DE) 2016-06-28 US disclosed
US-20150210686-A1 (AZA-)ISOQUINOLINONE DERIVATIVES MERCK PATENT GMBH (DE) 2015-07-30 US disclosed
US-20150210686-A1 (AZA-)ISOQUINOLINONE DERIVATIVES MERCK PATENT GMBH (DE) 2015-07-30 US disclosed
US-20150210686-A1 (AZA-)ISOQUINOLINONE DERIVATIVES MERCK PATENT GMBH (DE) 2015-07-30 US disclosed
EP-2882714-A2 (AZA-)ISOQUINOLINONE DERIVATIVES Merck Patent GmbH (DE) 2015-06-17 EP disclosed
WO-2014023390-A2 (AZA-)ISOQUINOLINONE DERIVATIVES MERCK PATENT GMBH (DE) 2014-02-13 WO disclosed
WO-2014023390-A2 (AZA-)ISOQUINOLINONE DERIVATIVES MERCK PATENT GMBH (DE) 2014-02-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150210686-A1 (AZA-)ISOQUINOLINONE DERIVATIVES TANK, TNKS, TDP1 PTGES 767/4885MITF 3345/4885MAOB 751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.